Total Health
C

CNS Metastasis in Breast Cancer: Surgery & Radiation Considerations

By Total Health FEATURING Cesar Santa-Maria
By Total Health FEATURING Cesar Santa-Maria
240 views
February 29, 2024
Check out related topics by Dr. Santa-Maria:
1) Systemic Therapy for HER2+ CNS Disease: Management of Breast Cancer Brain Mets
2) Systemic Therapy for HER2- CNS Disease: Management of Breast Cancer Brain Mets
Comments 0
Login to view comments. Click here to Login

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Related Videos

25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

4.3K views
06:51

SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer

Sara Tolaney

H. Rugo

556 views
20:32

ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Bre…

2024 ESMO Annual Meeting Insights Hub

S. Tolaney, H. Rugo

556 views
09:12

ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, …

2024 ESMO Annual Meeting Insights Hub

V. Kaklamani

539 views
20:25

ESMO 2024 Summary: Highlights in mBC

2024 ESMO Annual Meeting Insights Hub

G. Bianchini

533 views
29:24

ESMO 2024 Summary: Breast Cancer Highlights - AURORA Program, DAISY …

2024 ESMO Annual Meeting Insights Hub

C. Sotiriou

544 views
04:03

Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in m…

Fernanda Mosele

371 views
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views
33:44

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

931 views
19:15

Benefits of Oral Formulations in HR+/HER2- mBC: Reducing Time Toxici…

Priya Tiwari

501 views
11:54

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

462 views
15:25

Evolution of Treatment Algorithms for HER2+ mBC

RWJBarnabas Health Rutgers Cancer Institute of New Jersey

M. George

374 views
12:35

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+ mBC?"

Insights from 2023 SABCS

S. Tolaney, H. Rugo

3.0K views
35:39

Clinical Roundtable: HR+ BC Early Stage & Metastatic Disease Updates

Integrity CE

S. Graff, S. Dent, S. Gandhi

238 views
23:59

Serial CDK4/6 Inhibitor Therapy for HR+-HER2- MBC: Evolving Insights…

Seth Wander

590 views
14:16

Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

2.4K views
11:05

ESMO 2024 Insights: DESTINY-Breast06 Trial - HER2-Low and HER2-Ultra…

2024 ESMO Annual Meeting Insights Hub

G. Viale

363 views
15:41

mBC Updates: DESTINY-Breast06 Trial - 1L T-DXd vs. Chemo in HR+ HER2…

Claudine Isaacs

232 views
10:34

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

932 views
09:26

DESTINY-Breast06 - T-DXd vs. Physician’s Choice of Chemotherapy in H…

2024 ASCO® Annual Meeting Insights Hub

G. Curigliano

747 views
AUTOPLAY